SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing a sharp, volatile sell-off as investors rapidly unwind positions, causing the ETF to trade more like a high-beta tech stock than a traditional safe haven. The community is actively debating whether this is a forced liquidity event driven by margin calls and profit-taking or a fundamental shift in gold's status amid rising yields, a strengthening dollar, and geopolitical instability.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust is experiencing intense selling pressure and high volatility, with the community actively debating whether the current drop represents a generational buying opportunity or a deeper correction toward support levels near 50-60 dollars. Traders are largely attributing the decline to a broader liquidity crisis, rising yields, and a stronger dollar, while long-term investors emphasize physical silver demand and industrial shortages as reasons to hold despite the current market bloodbath.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is surging due to a massive volume spike driven by geopolitical tensions in the Middle East, specifically reports of supply disruptions at Qatar's LNG facilities that have heightened concerns over energy security in Europe. The community is actively discussing the stock's potential as a multi-day runner, with many traders drawing parallels to past energy sector volatility while debating the impact of the ongoing conflict on natural gas supply.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp is currently trending as investors monitor ongoing supply chain concerns and the company's role as a critical, U.S.-based supplier of antimony for defense and high-tech applications. The community is actively discussing the impact of geopolitical tensions, government contract backlogs, and recent earnings, with many focusing on the potential for institutional accumulation and the long-term strategic necessity of domestic mineral production.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is experiencing significant market attention as investors weigh robust vehicle delivery projections and positive operational developments against persistent volatility, driven in part by ongoing discussions regarding potential share dilution and broader macroeconomic headwinds. The community is actively debating the company's long-term potential, with bulls highlighting the expansion of its battery swap infrastructure and in-house chip technology as key competitive advantages, while skeptics remain cautious due to historical stock price performance and the impact of frequent trading of options.

WeShop Holdings Ltd. engages in providing a shoppable social network. It offers shopping in fashion and accessories, health and beauty, home and DIY, food and drink, travel and holidays, tech and electronics, and other popular categories. It includes a library of shoppable product reviews from a digital online shopping mall on mobile devices. The company was founded by John Garner on September 21, 2012 and is headquartered in Jersey, the United Kingdom.

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings is trending as investors react to the company's recent direct listing and community-owned commerce model, which has fueled intense retail speculation and volatility. Community discussion is sharply divided, with bulls highlighting potential growth from retail partnerships and aggressive expansion efforts, while skeptics point to the company's thin float and concerns over its long-term financial viability.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is currently in the spotlight as investors grapple with the fallout from federal indictments against former employees and a co-founder for a sophisticated chip-smuggling scheme to China. While some community members are bracing for further volatility and potential delisting risks, others argue the sell-off is an overreaction, pointing to the company's status as a victim in the indictment and its strong underlying position in the AI infrastructure market.

Two Harbors Investment Corp. is a real estate investment trust, which invests in finances, and manages agency residential mortgage-backed securities, mortgage servicing rights, and other financial assets. The company was founded on May 21, 2009 and is headquartered in St. Louis Park, MN.

Two Harbors Investment Corp

Two Harbors Investment Corp. is trending due to an unsolicited all-cash acquisition offer of $10.70 per share, prompting an active community debate over whether the bid represents a superior proposal compared to the existing UWM Holdings merger agreement. Investors are closely analyzing the offer against the company's underlying book value and debating the likelihood of a higher counter-offer amid ongoing market volatility.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining is drawing significant investor attention due to record-breaking quarterly financial performance and the highly anticipated completion of its merger with New Gold. The community is actively debating the stock's potential for a major re-rating, fueled by strong gold and silver production levels and broader optimism across the precious metals sector.

ProShares Trust - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver (AGQ) is facing extreme volatility and a sharp downward slide as investors grapple with massive price swings, liquidations, and heightened anxiety over the sustainability of recent rallies. The community is actively debating whether this is a structural market reset driven by technical manipulation and shifting institutional flows, or a temporary cooling period for a commodity previously inflated by aggressive sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Enanta Pharmaceuticals Pitches RSV Phase 3 Plans, Expands Oral Immunology Pipeline at Citizens Conference

Enanta Pharmaceuticals (NASDAQ:ENTA) used a presentation at the Citizens Life Sciences Conference to outline its evolving pipeline strategy, highlighting late-stage ambitions in respiratory syncytial...

Commodore Capital LP Buys New Holdings in Enanta Pharmaceuticals, Inc. $ENTA

Commodore Capital LP purchased a new position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund...

Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that...

What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock

Enanta Pharmaceuticals (ENTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Equities Analysts Issue Forecasts for ENTA Q2 Earnings

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Free Report) - Research analysts at HC Wainwright raised their Q2 2026 EPS estimates for Enanta Pharmaceuticals in a report released on Tuesday, February...

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of +21.50% and +19.52%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Enanta Pharmaceuticals (NASDAQ:ENTA) Posts Earnings Results, Beats Estimates By $0.12 EPS

Enanta Pharmaceuticals (NASDAQ:ENTA - Get Free Report) posted its earnings results on Monday. The biotechnology company reported ($0.42) earnings per share for the quarter, beating the consensus...

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven research firms that are covering the firm, MarketBeat...

Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections and immunological...

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Current Price	$12.51
Prev Close	$13.00
Open	$13.00
Dividend Yield	0.00%
50-Day Moving Average	$13.51
Beta	1.11
Avg. Volume	200,257.19
PE Ratio	-3.90

52-Week High	$17.15
52-Week Low	$4.09
Market Capitalization	$363.03M
EPS (Annual)	-$3.84
Price to Book	2.87
Revenue Per Employee	$544,366.67

ENTA
Enanta Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ENTA News

ENTAEnanta Pharmaceuticals Inc